Physician

Amy Waronker-Silverstein, M.D.

According to 2025 Medicare claims, Amy Waronker-Silverstein, M.D. (NPI: 1912905779) practices endocrinology in the Camden, NJ market, with the plurality of this provider's patient population coming from Burlington, NJ. This provider's primary affiliated billing organization is VIRTUA MEDICAL GROUP, PA (NPI: 1649226515; TIN: 271348772) and primary practice location at 08057-3132.

Waronker-Silverstein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 328 traditional Medicare patients, billed 1,200 HCPCS/CPT codes, and received $68,624 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,122 prescription claims across 430 beneficiaries totaling $1,061,954 in drug costs, led by Trulicity (Dulaglutide). DME data shows 200 claims. Open Payments data shows 2 records totaling $35. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $241,316 to $1,061,954. For DME billing, reported payments moved sharply higher in recent years, from $2,480 to $55,973.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	447	813	$62,006
2016	444	879	$66,486
2017	400	763	$57,130
2018	382	739	$54,421
2019	352	840	$55,280
2020	297	650	$44,128
2021	322	753	$60,088
2022	328	1,124	$67,423
2023	318	965	$62,764
2024	328	1,200	$68,624

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	251	1,047	$241,316
2016	242	977	$241,738
2017	312	1,889	$604,178
2018	339	2,633	$890,503
2019	354	2,637	$939,129
2020	385	3,096	$1,169,843
2021	405	3,292	$1,408,678
2022	417	3,375	$1,498,358
2023	415	3,121	$1,472,707
2024	430	3,122	$1,061,954

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	92	186	$3,449
2016	45	71	$1,207
2017	55	91	$2,187
2018	89	166	$4,264
2019	89	219	$12,828
2020	94	282	$15,294
2021	86	229	$14,698
2022	85	308	$30,466
2023	75	325	$39,959
2024	90	200	$54,111

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	11	11	$139
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	249	474	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	62	70	$71
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	36	74	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trulicity	Dulaglutide	102	6,256	$205,132
Januvia	Sitagliptin Phosphate	165	11,077	$181,302
Ozempic	Semaglutide	98	5,912	$180,599
Mounjaro	Tirzepatide	44	2,076	$73,151
Tradjenta	Linagliptin	59	4,000	$65,524

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	31	90	$49,891
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	13	13	$2,743
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	34	76	$1,437
A4259	Lancets, per box of 100	N	12	21	$40

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$35	SANOFI-AVENTIS U.S. LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amy Waronker-Silverstein, M.D.?

Tedicare shows public-source Medicare data for Amy Waronker-Silverstein, M.D. (NPI 1912905779), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amy Waronker-Silverstein, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amy Waronker-Silverstein, M.D.?

Amy Waronker-Silverstein, M.D. is linked to VIRTUA MEDICAL GROUP, PA (billing NPI 1649226515) in the available physician profile data.

Does Amy Waronker-Silverstein, M.D. have Open Payments data?

Amy Waronker-Silverstein, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.